drugset / Trial / NCT06267820

Combined Ketorolac Bupivacaine Versus Bupivacaine Alone for TAP Block in Children Undergoing Lower Abdominal Surgeries

NCT06267820

Phase 2 Completed 90 enrolled Sohag University
RandomizedParallel-groupQuadruple-blindHealth-services research

Summary

Control of of pain in children is fundamental. TAP block is associated with less side effects compared with other neuraxial techniques especially when done under ultrasound guidance. Ketorolac has analgesic effect comparable to morphine. Children were arranged randomly into two equal groups, forty-five children in each. Group (K) (n= 45): received ultrasound guided TAP block with bupivacaine 0.25% (0.5 ml/kg) and ketorolac (0.5 mg/kg). Group (T) (n =45): received ultrasound guided TAP block with bupivacaine 0.25% (0.5 ml/kg)

Timeline

Start
2023-06-01
Primary completion
2023-12-01
Completion
2023-12-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.25 %
Comparator Bupivacaine Other / unclassified 0.5 unknown
Comparator Ketorolac Other / unclassified 0.5 mg/kg

Indications

No indication recorded.